JBIOJade Biosciences Inc. Common Stock
21.34USD-5.37%Mkt Cap: 1.36B $P/E: —3d ago
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to bl…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.36B $
Enterprise Value890.36M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-127.41M $
Revenue/Share—
Last Price21.34 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees55
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.97
PEG—
EV/EBITDA-5.41
EV/Revenue—
P/S—
P/B3.07
EPS (TTM)-1.01
EPS (Forward)-2.66
52W Range
6.71069% of range28.00
52W High28.00 USD
52W Low6.710 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-38.32%
ROA-36.43%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-94.69M $
CapEx (TTM)196.00K $
FCF Margin—
FCF Yield—
Net Debt-459.82M $
Net Debt/EBITDA2.79
Balance Sheet
Debt/Equity0.00
Current Ratio14.93
Quick Ratio14.61
Book Value/Sh6.922 USD
Cash/Share7.252 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 28, 2025
Splits
Last Split1:35
Split DateApr 29, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)50.13 USD
Upside (mean)+134.9%
Target Range40.00 USD – 77.00 USD
$40.00+134.9% to mean$77.00
# Analysts8
Ownership
Shares Out.63.60M
Float51.97M
Insiders0.79%
Institutions115.86%
Short Interest
Short Ratio9.6d
Short % Float16.74%
Short % Out.13.67%
Shares Short8.69M
Short (prev mo.)8.15M
Technical
SMA 5020.68 (+3.2%)
SMA 20017.40 (+22.7%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)868.02K
Avg Vol (10d)804.21K
Technical Indicators
RSI (14)48.5
MACD0.6639
MACD Signal0.5927
MACD Hist.+0.0712
BB Upper24.69 USD
BB Middle21.40 USD
BB Lower18.11 USD
BB Width30.79%
ATR (14)1.528 USD
Vol Ratio (20d)0.69x